MANGALAM2025-01-012025-03-31MANGALAM2025-03-31MANGALAM2024-03-31MANGALAM2024-04-012025-03-31MANGALAM2025-01-012025-03-31in-capmkt:OtherExpenses1MemberMANGALAM2024-04-012025-03-31in-capmkt:OtherExpenses1MemberMANGALAM2025-01-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss1MANGALAM2024-04-012025-03-31ItemsThatWillNotBeReclassifiedToProfitAndLoss1MANGALAM2025-01-012025-03-31AuditorDomain1iso4217:INRiso4217:INRxbrli:shares532637MANGALAMNOTLISTEDINE584F01014MANGALAM DRUGS AND ORGANICS LIMITEDMain BoardEquity2024-04-012025-03-312025-05-172025-05-14INRLakhsQuarterlyFourth quarterSingle segmentManufacturing of Bulk drugs2025-05-1717:00:002025-05-1719:30:00trueCash Flow IndirectDeclaration of unmodified opinion2025-01-012025-03-31AuditedConsolidated730386000210400073249000041763900061871000-125861000105034000403010004704200017011900071614500016345000016345000727000150240001575100005940000000594000-1959000-13650000000158282000100.040.04000.040.041 The above financial results have been prepared in accordance with Indian Accounting Standard (Ind AS) notified under section 133 of the Companies Act 2013 read together with Companies (Indian Accounting Standard) Rules 2015 and relevant amendment rules thereafter. <BR> 2 The above audited consolidated financial results of the Company for the Quarter and year ended have been reviewed by the Audit Committee and thereafter approved and taken on record by the Board of Directors of the Company (Mangalam Drugs and Organics Limited) at their meeting held on May 17 2025. <BR> 3 The Company's business activity falls within a single reportable Business Segment Viz. Manufacturing of Bulk Drugs. <BR> 4 The figures for the quarter ended 31st March 2025 are the balancing figures between the figures in respect of full financial year upto 31st March 2025 and the unaudited published year-to-date figures upto 31st December 2024 being the date of the end of the third quarter of the financial year respectively whichever subjected to limited review. <BR> 5 Consolidated results includes results of Mangalam Laboratories Private Limited subsidiary for the purpose of Consolidated results. <BR> 6 As on september 30 2023 the Company has acquired 3010 Equity shares of Mangalam Laboratories Private Limited of Rs. 100 each. Mangalam Laboratories Private Limited became a wholly owned subsidiary of the Company .The wholly owned subsidiary is not a material subsidiary of the Company on acquisition. <BR> 7 The Board of Directors of the Company at its meeting held on March 15, 2024 had considered and approved the scheme of Merger by Absorption of Mangalam Laboratories Private Limited (First Transferor Company) and Shri JB Pharma Private Limited (Formerly known as Shri JB Pharma LLP) (Second Transferor Company) with Mangalam Drugs and Organics Limited (Transferee Company) and their respective shareholders under Sections 230 to 232 and other applicable provisions of the Companies Act 2013. The Scheme is subject to approval of Hon’ble National Company Law Tribunal the shareholders and creditors of each of the companies. <BR> 8 Other Expenses <BR> Rs in Lakhs <BR> Sr.No Particulars Quarter Ended Year Ended <BR> 31.03.2025 31.12.2024 31.03.2024 31.03.2025 31.03.2024 <BR> Audited Unaudited Audited Audited Audited <BR> 1 Power and Fuel Expenses 663.33 671.89 833.90 2,788.76 2,849.67 <BR> 2 Pollution Control Expenses 269.30 182.81 224.32 901.14 854.78 <BR> <BR> 9 The figures for the previous periods have been regrouped wherever necessary to confirm to the current periods under presentation. <BR> <BR> 2024-04-012025-03-31AuditedConsolidated3182302000502600031873280001705616000183279000-215220000405871000149326000166070000744528000313947000047858000047858000827000-20176000-193490000672070000000672070006465500013186200000001582820001012606960004.254.25004.254.25Other Expenses170119000Other Expenses74452800013359570000002913550002694800000440000091600096000001916000016743800001388018000039072900025889000010939000548570004824140000119405000198983700000366421700015828200013315080001489790000014897900009232800000025165000117493000098153000042787000258433000719373000725040008389810009114850001254410001756299000139476000110410009178000019159940000021744270003664217000149326000-151621000-111284000046373000028300000024986200005541500001660700000-40170000704000-160310000400000-8713000000003789100004267680000008270000425941000000000007284000202012000000000000000000004000000-19472400000000000-6779800000014932600000-217124000140930000140930001179600025889000Other comprehensive income [Abstract]-1959000-1959000Other comprehensive income [Abstract]64655000646550000000-195900064655000AuditedtrueM/s. V. S. Somani & Co.true2027-07-31